Clinical trial · Observational
Head and Neck cancERs International cOviD-19 collabOraTion
HERODOTUS: Head and Neck cancERs International cOviD-19 collabOraTion
NCT04632173CI-TRIAL-00057172unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To develop an International registry on head and neck cancer patients infected with COVID-19
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Covid19 | — | UNRESOLVED | — |
| Head and Neck Cancer | Malignant Head and Neck Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| non interventional study | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (7)
- measure
- Demographic features
- timeFrame
- Nov 1 2019 to January 31 2021
- description
- age, performance status etc
- measure
- prevalence of comorbidities in head and neck cancer patients with COVID-19
- timeFrame
- Nov 1 2019 to January 31 2021
- measure
- proportion of head and neck cancer patients experiencing severe adverse events
- timeFrame
- Nov 1 2019 to January 31 2021
- measure
- proportion of head and neck cancer patients by COVID-19 clinical course severity
- timeFrame
- Nov 1 2019 to January 31 2021
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 100 Years
Show eligibility criteria text
Inclusion Criteria: Any head and neck cancer patients (including salivary gland, thyroid, nasal and paranasal cancer with a COVID-19 diagnosis defined as any of the following: * Laboratory confirmed \[Real Time - Polymerase Chain Reaction (RT-PCR) technique\] COVID-19. * Suspected COVID-19 cases; diagnosed clinically based on symptoms (fever \>37.5°, decrease of oximeter saturation of at least 5 %, cough, diarrhoea, otitis, dysgeusia, anosmia, myalgia, arthralgia, conjunctivitis and rhinorrhea and exposure to confirmed COVID-19 positive case (laboratory confirmation). * Clinically diagnosed cases; suspected cases with lung imaging features consistent with coronavirus pneumonia. * Asymptomatic cases; diagnosed based on positive viral nucleic acid test results but without any COVID- 19 symptoms Exclusion Criteria: \-
References
Publications (0)
Data not yet available
No reference posted for this study.